I'm not defending the moral argument, but I think in terms of ROI you could only argue that Moderna got underpaid by the US government based on what they delivered.
Once the genie is out of the bottle those companies will be international competitors with your trade secrets probably forever- they might be able to lock it back down in the US market but good luck convincing other states to shackle their pharmaceutical industry that way.
If Moderna makes a few bucks along the way, that's great. If Modern a can't survive without massive profits, I am OK if they go away as well.
Then why don't you advocate for the US to buy those doses and send then around the world. Why don't you start a fund that buys vaccines and sends them around the world?
You want it all at zero cost to yourself. Now you can understand why Moderna doesn't want to be footing the bill for the entire world.
...
> WHO's Friede is less convinced that there will soon be sufficient COVID vaccine supply.
> But even if that's the case, he says it will still be enormously valuable to have cracked the code of mRNA production on behalf of low and middle income producers.
Hard to feel sorry about a biotech's inability to export IP protection capitalism during a pandemic because of statements they themselves made.
EDIT: "All in all, U.S. agencies committed about $2.5 billion to help develop Moderna’s vaccine and buy doses, according to the New York Times."
https://www.usatoday.com/story/news/factcheck/2020/11/24/fac...
https://www.nytimes.com/2020/11/16/health/Covid-moderna-vacc...
Feels like everyone's "square" if Moderna continues to sell doses to countries that can afford it and countries that can't produce bootleg versions, but I am open to arguments as to why that wouldn't be the case based on all available data.